Phase II study of the EGFR TKI re-challenge with afatinib...

  • Main
  • 2016 / 7
  • Phase II study of the EGFR TKI re-challenge with afatinib...
Clinical Lung Cancer 2016 / 7

Phase II study of the EGFR TKI re-challenge with afatinib in patients with advanced NSCLC harboring sensitive EGFR mutation without T790M: Okayama Lung Cancer Study Group trial OLCSG 1403

Oda, Naohiro, Ichihara, Eiki, Hotta, Katsuyuki, Ninomiya, Kiichiro, Ninomiya, Takashi, Kubo, Toshio, Minami, Daisuke, Murakami, Toshi, Yokoyama, Toshihide, Harada, Daijiro, Kuyama, Shoichi, Ichikawa,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2016.07.003
Date:
July, 2016
File:
PDF, 804 KB
english, 2016
Conversion to is in progress
Conversion to is failed